Literature DB >> 2410551

Characterization of major structural proteins of measles virus with monoclonal antibodies.

T A Sato, A Fukuda, A Sugiura.   

Abstract

We have prepared and characterized monoclonal antibodies against five major structural proteins, i.e. the HA, P, NP, F and M proteins, of measles virus. At least three non-overlapping antigenic sites were delineated on the HA protein, three on the P, four on the NP, four on the F and five on the M proteins by competitive binding assays. Antigenic sites on the HA and F proteins roughly represented functional domains defined by serological tests. The reactivity of monoclonal antibodies with various measles virus strains including those from subacute sclerosing panencephalitis (SSPE) and other members of the morbillivirus family was studied by immunofluorescence. A monoclonal antibody or set of monoclonal antibodies to each of the antigenic sites showed a characteristic pattern of cross-reactivity with heterologous strains. The HA and NP proteins were antigenically the most variable, followed by the F and M proteins, while the P protein was relatively stable. None of the 14 anti-M monoclonal antibodies reacted with non-virus-producing SSPE cells, strongly suggesting the absence of M protein in these cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410551     DOI: 10.1099/0022-1317-66-7-1397

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Recombinant wild-type and edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity.

Authors:  Kaoru Takeuchi; Makoto Takeda; Naoko Miyajima; Fumio Kobune; Kiyoshi Tanabayashi; Masato Tashiro
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Analysis of viral antigens in giant cells of measles pneumonia by immunoperoxidase method.

Authors:  T Sata; T Kurata; Y Aoyama; M Sakaguchi; K Yamanouchi; K Takeda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  Mice immunized with measles virus develop antibodies to a cell surface receptor for binding virus.

Authors:  D L Krah; P W Choppin
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

4.  Structural defect linked to nonrandom mutations in the matrix gene of biken strain subacute sclerosing panencephalitis virus defined by cDNA cloning and expression of chimeric genes.

Authors:  M Ayata; A Hirano; T C Wong
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.

Authors:  J A Beeler; K van Wyke Coelingh
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

6.  Intracellular processing of measles virus fusion protein.

Authors:  T A Sato; T Kohama; A Sugiura
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

7.  A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism.

Authors:  Makoto Takeda; Maino Tahara; Takao Hashiguchi; Takeshi A Sato; Fumiaki Jinnouchi; Shoko Ueki; Shinji Ohno; Yusuke Yanagi
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

8.  Detection of rinderpest virus using N-protein monoclonal antibodies.

Authors:  R A Shah; M C Joseph; G Butchaiah; M Malik; R K Singh; C S Bakshi
Journal:  Trop Anim Health Prod       Date:  2004-01       Impact factor: 1.559

9.  Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis.

Authors:  K Baczko; U G Liebert; M Billeter; R Cattaneo; H Budka; V ter Meulen
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

10.  The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope.

Authors:  Maino Tahara; Shinji Ohno; Kouji Sakai; Yuri Ito; Hideo Fukuhara; Katsuhiro Komase; Melinda A Brindley; Paul A Rota; Richard K Plemper; Katsumi Maenaka; Makoto Takeda
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.